ONC1-13B
Product Specifications
UNSPSC Description
ONC1-13B is a potent androgen receptor (AR) antagonist with the activity of effectively inhibiting PSA expression in prostate cancer cells. ONC1-13B can effectively inhibit PSA expression and prostate cancer cell proliferation under DHT stimulation. ONC1-13B exerts its anti-tumor effect by preventing androgen from binding to AR and its nuclear translocation[1].
Target Antigen
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/onc1-13b.html
Smiles
O=C1[C@]2(CCOC2)N(C3=CC(F)=C(C=C3)C(NC)=O)C(N1C4=CC(C(F)(F)F)=C(C=C4)C#N)=S
Molecular Weight
492.45
References & Citations
[1]Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-114246/ONC1-13B-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-114246/
Clinical Information
No Development Reported
CAS Number
1351185-54-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
